<VariationArchive RecordType="classified" VariationID="374397" VariationName="NM_016180.5(SLC45A2):c.163dup (p.Tyr55fs)" VariationType="Duplication" Accession="VCV000374397" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-01-13" MostRecentSubmission="2017-01-13">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="361183" VariationID="374397">
      <GeneList>
        <Gene Symbol="SLC45A2" FullName="solute carrier family 45 member 2" GeneID="51151" HGNC_ID="HGNC:16472" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="33944623" stop="33984693" display_start="33944623" display_stop="33984693" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NT_187551.1" start="145945" stop="155829" display_start="145945" display_stop="155829" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="33944720" stop="33984779" display_start="33944720" display_stop="33984779" Strand="-" />
          </Location>
          <OMIM>606202</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_016180.5(SLC45A2):c.163dup (p.Tyr55fs)</Name>
      <CanonicalSPDI>NC_000005.10:33984420:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="33984420" stop="33984421" display_start="33984420" display_stop="33984421" variantLength="1" positionVCF="33984420" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="33984525" stop="33984526" display_start="33984525" display_stop="33984526" variantLength="1" positionVCF="33984525" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>Y55fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.33984421dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.33984421dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.33984526dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.33984526dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011691.2" sequenceAccession="NG_011691" sequenceVersion="2" change="g.5255dup">
            <Expression>NG_011691.2:g.5255dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001012509.4" sequenceAccession="NM_001012509" sequenceVersion="4" change="c.163dup">
            <Expression>NM_001012509.4:c.163dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001012527.2" sequenceAccession="NP_001012527" sequenceVersion="2" change="p.Tyr55fs">
            <Expression>NP_001012527.2:p.Tyr55fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001297417.4" sequenceAccession="NM_001297417" sequenceVersion="4" change="c.163dup">
            <Expression>NM_001297417.4:c.163dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001284346.2" sequenceAccession="NP_001284346" sequenceVersion="2" change="p.Tyr55fs">
            <Expression>NP_001284346.2:p.Tyr55fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016180.5" sequenceAccession="NM_016180" sequenceVersion="5" change="c.163dup" MANESelect="true">
            <Expression>NM_016180.5:c.163dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057264.4" sequenceAccession="NP_057264" sequenceVersion="4" change="p.Tyr55fs">
            <Expression>NP_057264.4:p.Tyr55fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16043661" DB="ClinGen" />
        <XRef Type="rs" ID="1057518722" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016180.5(SLC45A2):c.163dup (p.Tyr55fs) AND Oculocutaneous albinism type 4" Accession="RCV000415377" Version="1">
        <ClassifiedConditionList TraitSetID="1241">
          <ClassifiedCondition DB="MedGen" ID="C1847836">Oculocutaneous albinism type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-13" MostRecentSubmission="2017-01-13">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1241" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5663" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Oculocutaneous albinism type 4</ElementValue>
                <XRef ID="Oculocutaneous+albinism%2C+type+4/9033" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011683" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type IV</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA4</ElementValue>
                <XRef Type="MIM" ID="606574" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Oculocutaneous albinism type 4 (OCA4) is characterized by hypopigmentation of the hair and skin plus the characteristic ocular changes found in all other types of albinism, including: nystagmus; reduced iris pigment with iris translucency; reduced retinal pigment with visualization of the choroidal blood vessels on ophthalmoscopic examination; foveal hypoplasia associated with reduction in visual acuity; and misrouting of the optic nerves at the chiasm associated with alternating strabismus, reduced stereoscopic vision, and an altered visual evoked potential (VEP). Individuals with OCA4 are usually recognized within the first year of life because of hypopigmentation of the hair and skin and the ocular features of nystagmus and strabismus. Vision is likely to be stable after early childhood. The amount of cutaneous pigmentation in OCA4 ranges from minimal to near normal. Newborns with OCA4 usually have some pigment in their hair, with color ranging from silvery white to light yellow. Hair color may darken with time, but does not vary significantly from childhood to adulthood.</Attribute>
                <XRef ID="NBK1510" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301683</ID>
                <ID Source="BookShelf">NBK1510</ID>
              </Citation>
              <XRef ID="79435" DB="Orphanet" />
              <XRef ID="C1847836" DB="MedGen" />
              <XRef ID="MONDO:0011683" DB="MONDO" />
              <XRef Type="MIM" ID="606574" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="962963" SubmissionDate="2016-11-14" DateLastUpdated="2017-01-13" DateCreated="2017-01-13">
        <ClinVarSubmissionID localKey="chr5:33984526dupA|OMIM:606574" submittedAssembly="hg19" />
        <ClinVarAccession Accession="SCV000328843" DateUpdated="2017-01-13" DateCreated="2017-01-13" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Our laboratory reported dual molecular diagnoses in SLC45A2 (NM_016180.3:c.163dupT) and AVPR2 (NM_000054.4:c.335G&gt;T) in an individual with oculocutaneous albinism, nephrogenic diabetes insipidus, bilateral hydronephrosis, mild dysmorphic features, delayed motor milestones and hypotonia.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC45A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016180.3:c.163dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606574" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Dual_diagnosis_variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="962963" TraitType="Disease" MappingType="XRef" MappingValue="606574" MappingRef="OMIM">
        <MedGen CUI="C1847836" Name="Oculocutaneous albinism type 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

